Results 341 to 350 of about 177,501 (382)
Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga+7 more
wiley +1 more source
Treatment of pediatric severe acute myopericarditis with anakinra: a case report and literature review. [PDF]
Licciardi F+5 more
europepmc +1 more source
Abstract Background Cardiac myosin binding protein C (cMyC) is an emerging new biomarker of myocardial injury rising earlier and cleared faster than cardiac troponins. It has discriminatory power similar to high‐sensitive troponins in diagnosing myocardial infarction in patients presenting with chest pain. It is also associated with outcome in patients
E. Riveland+12 more
wiley +1 more source
Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report. [PDF]
Barker SB, Adewuyi A.
europepmc +1 more source
Outcomes and Predictors of Severity of Immunotherapy-Related Myocarditis. [PDF]
Idossa D, Herrmann J, Ruddy KJ.
europepmc +1 more source
Acute Kidney Injury and Viral Myocarditis Secondary to Acute Epstein-Barr Virus Infection. [PDF]
Santos Reis C+5 more
europepmc +1 more source
Myocarditis and Inflammatory Cardiomyopathy in Dilated Heart Failure. [PDF]
Nappi F.
europepmc +1 more source
Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study. [PDF]
Li FX+9 more
europepmc +1 more source